N/A
Completed N=60
A COmmunity and Tech-Based ApproaCh for Hypertension Self-MANagement
Hypertension · Self-management · Technology · Community-based Participatory Research
Source: ClinicalTrials.gov NCT03724487 ↗
Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Jun 2022
Primary outcomePrimary: Change in Systolic and Diastolic Blood Pressure — 0.55; -2.17; -0.80; -1.04 mm Hg
Summary
The prevalence of hypertension among U.S. adults increased from 32% to 46% and African Americans are disproportionately impacted. Self-managing hypertension presents challenges such as dealing with complex treatment regimen, including critical components of recommended hypertension treatment such as self-blood pressure monitoring, and lifestyle modifications involving diet, exercise, and tobacco cessation. African Americans with hypertension have lower adherence to self-management behavior due to multifactorial reasons. Substantial evidence has demonstrated the important role of community support in improving patients' self-management of a variety of chronic illnesses, though integrating technology in such programs are rarely offered.
The purpose of this study is to investigate the effectiveness of a community outreach program using a technology-based intervention (TBI) to support self-managing hypertension (called COACHMAN) to improve BP control.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Systolic and Diastolic Blood Pressure |
0.55; -2.17; -0.80; -1.04 | — |
| PRIMARY Change in PROMIS Global Health-10 [Health-related Quality of Life] |
0; 0.34; -0.11; -0.11 | — |
| SECONDARY Achieved Blood Pressure Target of < 130/80 mm Hg at 12 Weeks |
22 | — |
Eligibility Criteria
Inclusion Criteria
- self-identifying as African American
- age 30 years or older
- diagnosed with hypertension, with a blood pressure >140/80 mmHg
- prescribed at least one antihypertensive medication
- able to read and understand English
- own a smartphone
Exclusion Criteria
- history of cognitive impairment
- currently using a medication management app
Data sourced from ClinicalTrials.gov (NCT03724487). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.